SUBSCRIBE
SUBSCRIBE
News   Drug Development

Lexicon Pharmaceuticals, Inc. Diabetes Drug Trial Shows Promise

September 16, 2009 | 
1 min read
Bookmark and Share

Reuters -- Lexicon Pharmaceuticals Inc said its experimental diabetes drug proved to be safe and well tolerated in an early stage study, driving its shares to more than double in value.
Clinical research Phase 1
MORE ON THIS TOPIC
Brain shaped white jigsaw puzzle on blue background. Mental health and problems with memory.
Acadia slides on Phase 2 miss in Alzheimer’s psychosis but keeps moving asset forward
September 24, 2026
 · 
2 min read
 · 
Gabrielle Masson
Blue and yellow halftone eye of a beautiful girl.
Eye disease
Merck’s experimental eye drug matches Roche’s VEGF inhibitor but safety concerns emerge
September 24, 2026
 · 
2 min read
 · 
Annalee Armstrong
Hand shaking print screen on wooden block cube between human icon for business deal and agreement concept.
Deals
Roche inks up to $2B deal with Atavistik for new cardiometabolic drugs
September 24, 2026
 · 
2 min read
 · 
Gabrielle Masson
IN PARTNERSHIP WITH CURIUM
How radioligand therapy is rewriting cancer care
September 24, 2026
 · 
1 min read
 · 
Jennifer C. Smith-Parker